🇨🇦 increased dosing interval of biological therapy in Canada

increased dosing interval of biological therapy (increased dosing interval of biological therapy) regulatory status in Canada.

Marketing authorisation

increased dosing interval of biological therapy in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is increased dosing interval of biological therapy approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for increased dosing interval of biological therapy in Canada?

Rigshospitalet, Denmark is the originator. The local marketing authorisation holder may differ — check the official source linked above.